Search
for
Sort by
Research 691–720 of 1000+
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- Adolescent Male Androgenetic Alopecia with Iron Deficiency Anemia: A Case Treated with Individualized Homeopathy
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
- Plasma Therapy Gains Attention in Treatment of Viral Infections, Dermatological Illness, and Orthopedic Illnesses
- Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA
- JCD — Editorial Commentary, May, 2021
- Kaleidoscope
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Ann Robinson’s research reviews —12 May 2022
- Integrating Ayush practitioners in outbreak investigations in India: a call for action
- Coronavirus Infection and Cholesterol Metabolism
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- Reconnecting
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Designing the Future of Dermatology and Venereology
- JCD Editorial September 2021
- An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight